ALLERGY NITE 4 MG
CHLORPHENIRAMINE MALEATE : 4 MG · DIN 02450453 · BAYER INC
Health Canada status: CANCELLED PRE MARKET
What is ALLERGY NITE?
ALLERGY NITE 4 MG contains CHLORPHENIRAMINE MALEATE : 4 MG. It is listed in the Health Canada Drug Product Database under DIN 02450453, held by BAYER INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 02-Jun-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02450453 |
|---|---|
| Brand name | ALLERGY NITE |
| Generic / active ingredient | CHLORPHENIRAMINE MALEATE : 4 MG |
| Manufacturer | BAYER INC |
| Strength | 4 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R06AB04 CHLORPHENIRAMINE |
| AHFS class | 04:04.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 02-Jun-2021 |
What can be used instead?
Other Canadian products sharing ATC code R06AB04 CHLORPHENIRAMINE. 1 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TEVA-PHENIRAM | 4 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 00021288 |
| CHLOR-TRIPOLON | 4 MG | TABLET | BAYER INC | CANCELLED POST MARKET | DIN 00738972 |
| CHLOR-TRIPOLON 12 HOUR | 12 MG | TABLET (EXTENDED-RELEASE) | BAYER INC | CANCELLED POST MARKET | DIN 00738964 |
| CHLOR-TRIPOLON DAY AND NIGHT | 4 MG | TABLET (EXTENDED-RELEASE) ; KIT ; TABLET | SCHERING-PLOUGH CANADA INC | CANCELLED POST MARKET | DIN 02277123 |
| CHLOR-TRIPOLON NIGHT TIME ALLERGY RELIEF | 12 MG | TABLET | SCHERING-PLOUGH CANADA INC | CANCELLED PRE MARKET | DIN 02241291 |
| CHLORPHENIRAMINE MALEATE 4MG TABLET | 4 MG | TABLET | JAMP PHARMA CORPORATION | DORMANT | DIN 02265559 |
| CHLORPHENIRAMINE MALEATE INJECTION USP | 10 MG | LIQUID | OMEGA LABORATORIES LIMITED | CANCELLED PRE MARKET | DIN 02240953 |
| CHLORPHENIRAMINE MALEATE TAB 4MG | 4 MG | TABLET | BIONATAL DRUG CO | CANCELLED POST MARKET | DIN 00366706 |
| CHLORPHENIRAMINE MALEATE TAB 4MG | 4 MG | TABLET | EVEREST PHARMACEUTICALS LTD. | CANCELLED POST MARKET | DIN 00490571 |
| CHLORPHENIRAMINE TABLETS, 4 MG | 4 MG | TABLET | LOGAN PHARMACEUTICALS INC. | CANCELLED (UNRETURNED ANNUAL) | DIN 02358506 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.